Abstract
Abnormalities of lipid metabolism are one of the major health problems facing most developed countries. The combination of genetic factors, overeating, inappropriate balance of diet, lack of physical activity, smoking and alcohol consumption have led to an almost epidemic increased in cardiovascular disease, primarily coronary artery disease. In the USA, coronary artery disease is the leading cause of death, even though mortality is decreasing because of more effective medical and surgical treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Basic Science Aspects
Borgia MC, Medici F (1998) Perspectives in the treatment of dyslipidemias in the prevention of coronary heart disease. Angiology 49:339 – 348
Davignon J, Genest J Jr (1998) Genetics of lipoprotein disorders. Endocrinol Metab Clin North Am 27:521 – 550
Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N Eng J Med 276:34 – 42
Scriver CR, Beaudet AL, Sly WS et al. (eds) (1995) The metabolic and molecular bases of inherited disease, 7th edn. McGraw-Hill, New York
Xanthomas
Ahrens EH, Kunkel HG (1949) The relationship between serum lipids and skin xanthoma in eighteen patients with primary biliary cirrhosis. J Clin Invest 28:1565 – 1575
Braun-Falco O (1973)Origin, structure and function of the xanthoma cell. Nutr Metab 15:68 – 88
Braun-Falco O, Keller C, Zöllner N (eds) (1973) Xanthoma formation and other tissue reactions to hyperlipidemias. Karger, Basel
Cruz PD Jr, East C, Bergstresser PR (1988) Dermal, subcutaneous and tendon xanthomas: diagnostic markers for specific lipoprotein disorders. J Am Acad Dermatol 19: 95–111
Miller DM, Brodejl RT (1995) Eruptive xanthomatosis with linear koebnerization. J Am Acad Dermatol 33:834–835
Miwa N, Kanzaki T (1992) The Koebner phenomenon in eruptive xanthoma. J Dermatol 19:48 – 50
Parker F (1985) Xanthomas and hyperlipidemias. J Am Acad Dermatol 13:1–30
Xanthelasmas
Bergman R (1994) The pathogenesis and clinical significance of xanthelasma palpebrarum. J Am Acad Dermatol 30:236 – 242
Douste-Blazy P, Marcel YL, Cohen L et al. (1982) Increased frequency of Apo E-ND phenotype and hyperapobeta-lipoproteinemia in normolipidemic subjects with xanthelasmas of the eyelids. Ann Intern Med 96:164–169
Eedy DJ (1996) Treatment of xanthelasma by excision with secondary intention healing. Clin Exp Dermatol 21:273–275
Familial Hyperlipoproteinemia
Alagille D, Odievre M, Gautier M et al. (1975) Hepatic duc-rular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur. J Pediatr 86:63–71
Brown MS, Goldstein JL (1974) Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man. Science 185:61 – 63
Bürger M, Grütz O (1932) Über hepatosplenomegale Lipoidose mit Xanthomatösen Veränderungen in Haut und Schleimhaut. Arch Dermatol Syph 166:542 – 575
Frederickson DS, Altrocchi PH, Avioli LV et al. (1961) Tangier disease — combined clinical staff conference at the National Institutes of Health. Ann Intern Med 55:1016–1031
Innerarity TL, Weisgraber KH, Arnold KS et al. (1987) Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc Natl Acad Sci USA 84:6919–6923
Knopp RH (1999) Drug treatment of lipid disorders. NEJM 341:498–511
Thannhauser SJ, Magendantz H (1939) The different clinical groups of xanthomatous diseases: a clinical physiological study of 22 cases. Ann Intern Med 11:1662 – 1746
Utermann G, Jaeschke M, Menzel J (1975) Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins. FEBS Lett 56:352–355
Watson GH, Miller V (1973) Arteriohepatic dysplasia: familial pulmonary arterial stenosis with neonatal liver disease. Arch Dis Child 48:459 – 466
Weston CF, Burton JL (1987) Xanthomas in the Watson-Alagille syndrome. J Am Acad Dermatol 16:1117 – 1121
Normolipemic Xanthomatosis
Bhattacharyya AK, Connor WE (1974)β-Sitosterolemia and xanthomasosis. A newly described lipid storage disease in two sisters. J Clin Invest 53:1033 – 1043
Parker F (1986) Normocholesterolemic xanthomatosis. Arch Dermatol 122:1253 – 1257
van Bogaert L, Scherer H J, Epstein E (1937) Une forme cérébrale de la cholesterinose généralisée. Masson and Cic, Paris
Verruciform Xanthoma
Kimura S (1984) Verruciform xanthoma of the scrotum. Arch Dermatol 120:1378 – 1379
Kraemer BB, Schmidt WA, Foucar E et al. (1981) Verruciform xanthoma of the penis. Arch Dermatol 117:516 – 518
Meyers DC, Woosley JT, Reddick RL (1992) Verruciform xanthoma in association with discoid lupus erythematosus. J Cutan Pathol 19:156 – 158
Neville B (1986) The verruciform xanthoma. A review and report of eight new cases. Am J Dermatopathol 8:247–253
Nowparast B, Howell FV, Rick GM (1981) Verruciform xanthoma: A clinicopathologic review and report of fifty-four cases. Oral Surg Oral Med Oral Pathol 51:619–625
Shafer WG (1971) Verruciform xanthoma. Oral Surg Oral Med Oral Pathol 31:784 – 789
Yamamoto T, Katayama I, Nishioka K (1995) Verruciform xanthoma in a psoriatic patient under PUVA Therapy. Dermatology 191:254 – 256
Diffuse Normolipemic Plane Xanthomas
Altman J, Winkelmann RK (1962) Diffuse normolipidemic plane xanthoma. Arch Dermatol 85:633 – 640
Ginarte M, Peteiro C, Toribio J (1997) Generalized plane xanthoma and idiopathic Bence-Jones proteinuria. Clin Exp Dermatol 22:192 – 194
Lynch PJ, Winkelmann RK (1966) Generalized plane xanthoma and systemic disease. Arch Dermatol 93:639–646
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Braun-Falco, O., Plewig, G., Wolff, H.H., Burgdorf, W.H.C. (2000). Disorders of Lipoprotein and Lipid Metabolism. In: Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97931-6_37
Download citation
DOI: https://doi.org/10.1007/978-3-642-97931-6_37
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-97933-0
Online ISBN: 978-3-642-97931-6
eBook Packages: Springer Book Archive